Chiesi Farmaceutici is an international research-focused pharmaceutical company that researches, develops, and markets drugs in the respiratory therapeutics, neonatology, specialist medicine, and rare diseases areas.
Phone: +39 0521 2791
Via Palermo, 26/A
Parma, 43122
Italy
| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2016-11-21 | Atopix Therapeutics | Acquired | ||
| 2014-02-04 | Cornerstone Therapeutics | Acquired | ||
| 2013-08-26 | Zymenex | Acquired | ||
| 2013-07-10 | uniQure | Project Finance | $21.8M | |
| 2013-07-10 | uniQure | Series B | $36.1M | Coller Capital, Forbion Capital Partners, Gilde Healthcare Partners, and Lupus Alpha |
